NCT07286136

Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: FLO LIVING, LLC · Industry
• Sex: Female
• Age: 22 Years – 42 Years
• Healthy volunteers: Accepted

Summary

This 12-week, 100% virtual single-group open-label trial evaluates the Cycle SyncingⓇ Method using the MyFLO app, MIRA hormonal monitoring, and continuous glucose monitoring to assess reduction in menstrual cycle symptom burden and hormonal regulation.

Conditions

• Menstrual Cycle Disorder
• Menstrual Symptoms
• Hormonal Imbalance

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	MyFLO App	Participants follow the Cycle SyncingⓇ Method using the MyFLO app daily for 12 weeks. This includes personalized food and workout plans, symptom logging, hormonal testing with MIRA devices (urine and BBT), continuous glucose monitoring (CGM), and weekly virtual coaching sessions.

Timeline

• Start date: 2025-05-01
• Primary completion: 2025-10-01
• Completion: 2025-10-01
• First posted: 2025-12-16
• Last updated: 2025-12-16

Locations

1 site across 1 country: United States